SCHEMBL19954150

SCHEMBL19954150

CCCN[C@H](C)c1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
LMNA P02545 3/20 0.51
HTT P42858 3/20 0.51
KMT2A Q03164 3/20 0.51
MITF O75030 1/20 0.51
MAPT P10636 1/20 0.51
HTR1A P08908 2/20 0.48
HTR7 P34969 1/20 0.48
HTR6 P50406 1/20 0.48
CYP3A4 P08684 2/20 0.44
CHRM2 P08172 1/20 0.44
ADRA2A P08913 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
SMPD1 P17405 1/20 0.44
DRD1 P21728 1/20 0.44
TBXA2R P21731 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
ADRA1A P35348 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13137650 1.00 ALDH1A1 (0.51) ALDH1A1LMNAHTTKMT2AMITF
SCHEMBL25585953 0.83 HTT (0.47) ALDH1A1LMNAHTTKMT2AMITF
SCHEMBL12227624 0.83 HTT (0.47) ALDH1A1LMNAHTTKMT2AMITF
SCHEMBL13911226 0.83 HTT (0.47) ALDH1A1LMNAHTTKMT2AMITF
SCHEMBL13911202 0.82 SMN1; SMN2 (0.49) ALDH1A1LMNAHTTKMT2AMAPT
SCHEMBL13137645 0.82 SMN1; SMN2 (0.49) ALDH1A1LMNAHTTKMT2AMAPT
SCHEMBL8443448 0.80 HTR1A (0.48) ALDH1A1LMNAHTTKMT2AHTR1A
SCHEMBL13137649 0.80 ESR1 (0.47) ALDH1A1LMNAHTTKMT2AMAPT
SCHEMBL19954142 0.80 PSEN1 (0.36) ALDH1A1LMNAHTTKMT2AMITF
SCHEMBL3034755 0.80 CYP3A4 (0.44) ALDH1A1LMNAHTTKMT2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914740-B2 Tricyclic pyrido-carboxamide derivatives as rock inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-13 US disclosed